We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Researcher Patents Potential Vaccine Candidate for Syphilis

News   Apr 26, 2018 | Original story from University of Victoria

 
Researcher Patents Potential Vaccine Candidate for Syphilis

UVic microbiologist Caroline Cameron. Credit: UVic Photo Services

 
 
 

RELATED ARTICLES

Pathogen Engineered to Self-Destruct Underlies Cancer Vaccine Platform

News

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors.

READ MORE

Clinical Trial Assessing Treatments for Preventing People at High Risk From Developing Multidrug-resistant TB Launches

News

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB.

READ MORE

Gastric Stem Cells Fight Bacteria to Protect Themselves Against Cancer

News

Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. By actively fighting colonizing bacteria, gastric stem cells protect themselves against damage that can lead to cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE